WIZP Insider Trading Activity and SEC Form 4 Filings
WIZP insider trading summary
No open-market insider purchases or sales of Wize Pharma, Inc. (WIZP) have been reported on SEC Form 4 in the past 12 months.
Latest WIZP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 9, 2021 | Rimon Gold Assets Ltd | 10% Owner | Buy | $1.3M (10,833,333 @ $0.12) |
| Mar 9, 2021 | Or Eisenberg | CFO and Secretary | Buy | $100K (833,333 @ $0.12) |
| Mar 9, 2021 | Noam Danenberg | Chief Executive Officer | Buy | $350K (2,916,667 @ $0.12) |
| Mar 9, 2021 | Jonathan Brian Rubini | 10% Owner | Buy | $1.3M (10,416,667 @ $0.12) |
| Dec 29, 2020 | Jonathan Brian Rubini | 10% Owner | Sell | $0 (33,951 @ $0.00) |
| Dec 29, 2020 | Jonathan Brian Rubini | 10% Owner | Sell | $0 (2,159 @ $0.00) |
| Dec 29, 2020 | Rimon Gold Assets Ltd | 10% Owner | Sell | $0 (3,077 @ $0.00) |
| Dec 29, 2020 | Rimon Gold Assets Ltd | 10% Owner | Sell | $0 (2,919 @ $0.00) |
| Dec 29, 2020 | Noam Danenberg | Chief Executive Officer | Sell | $0 (507 @ $0.00) |
| Dec 29, 2020 | Noam Danenberg | Chief Executive Officer | Sell | $0 (12,543 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.